Vladislav Avdyshev

Dr. Vladislav Avdyshev

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2024 in Russian Journal of Evidence-Based Gastroenterology
Verified
Journal Article
Closed access
Vladislav AvdyshevVladislav Avdyshev
Vladislav Avdyshev
AKA.A. Kharlamova
A.A. Kharlamova
AKA.E. Kucher
A.E. Kucher
VSVladislav Sergeevich Skossyrskiy
Vladislav Sergeevich Skossyrskiy
SOS.V. Osipova
S.V. Osipova
CPChavdar Pavlov
Chavdar Pavlov
Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease that can lead to cirrhosis and its complications. The lack of strict diagnostic criteria for AIH complicates diagnosis and delays the initiation of appropriate therapy. Treatment selection and patient management remain challenges. Objective. To highlight the diagnostic and therapeutic aspects of AIH based on a clinical case. Clinical case. A 33-year-old female presented with significant cytolysis and cholestasis. A differential diagnosis ruled out viral hepatitis, liver storage diseases, and drug-induced liver injury (the patient had taken paracetamol and amoxicillin-clavulanate for a recent viral infection). Anti-SLA/LP antibodies were detected, while ANA, AMA, ANCA, SMA, and anti-LKM were within reference ranges. A liver biopsy revealed features of AIH and grade 1 steatosis. The final diagnosis was chronic AIH with high cytolytic activity, intrahepatic cholestasis, and parenchymal jaundice. Immunosuppressive therapy with prednisolone (40 mg/day) and azathioprine (50 mg/day) was initiated, with dosage adjustments for side effects. Despite four years of therapy, full biochemical and morphological remission was not achieved, and the risk of cirrhosis remains. This case underscores the challenges of diagnosing AIH and its potential overlap with cholestatic liver diseases. The article also discusses the need to monitor therapy-related side effects and the role of thiopurine S-methyltransferase testing in treatment. Conclusion. The heterogeneity of AIH symptoms complicates early diagnosis. A comprehensive approach, including autoantibody testing and imaging, is essential for timely and accurate diagnosis.

20 February 2026 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
AFA.P. Fabrika
A.P. Fabrika
Vladislav AvdyshevVladislav Avdyshev
Vladislav Avdyshev
EDE.I. Dybalyuk
E.I. Dybalyuk
GUG.D. Utrosin
G.D. Utrosin
KKK.A. Kammaev
K.A. Kammaev
ETE.A. Tarabrin
E.A. Tarabrin
The article presents a rare clinical case of examination and treatment of a patient with stage IIIA lung squamous cell carcinoma. After neoadjuvant chemotherapy using the standard regimen of paclitaxel-carboplatin (6 injections), a complete pathomorphological response was achieved based on the results of histological and immunohistochemical examination of the postoperative material. During 12 months of follow-up, no recurrences were observed. In light of the results obtained, the issue of the potential benefits of omitting the surgical treatment stage after achieving a complete pathomorphological response to neoadjuvant chemotherapy is raised. Further prospective studies are needed to confirm these conclusions.